Search

Author/Creator Huang, Litang

1. Flotillin-1 enhances radioresistance through reducing radiation-induced DNA damage and promoting immune escape via STING signaling pathway in non-small cell lung cancer. Issue 1 (31st December 2023)

Authors:
Wang, Yingying; Meng, Lu; Meng, Shuyan; Huang, Litang; Luo, Shilan; Wu, Xiaoting; Gong, Xiaomei
Journal:
Cancer biology & therapy
Issue:
Volume 24:Issue 1(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Host stimulator of interferon genes is essential for the efficacy of anti‐programmed cell death protein 1 inhibitors in non‐small cell lung cancer. Issue 4 (11th September 2022)

Authors:
Zhou, Li; Xu, Qiuli; Huang, Litang; Zhan, Ping; Jin, Jiajia; Ye, Mingxiang; Liu, Hongbing; Zhang, Fang; Wang, Zimu; Liu, Jiaxin; Chen, Cen; Han, Hedong; Zhang, Qun; Zhu, Suhua; Ren, Jianan; Lv, Tangfeng; Song, Yong
Journal:
Immunology
Issue:
Volume 167:Issue 4(2022)
Page Start:
495
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer. (1st March 2021)

Authors:
Zhou, Li; Xu, Qiuli; Huang, Litang; Jin, Jiajia; Zuo, Xueying; Zhang, Qun; Ye, Liang; Zhu, Suhua; Zhan, Ping; Ren, Jianan; Lv, Tangfeng; Song, Yong
Journal:
Cancer letters
Issue:
Volume 500(2021)
Page Start:
163
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗